The Expanded Risk Score in Rheumatoid Arthritis (ERS-RA): performance of a disease-specific calculator in comparison with the traditional prediction scores in the assessment of the 10-year risk of cardiovascular disease in patients with rheumatoid arthritis
AIMS OF THE STUDY To assess the performance of the Expanded Risk Score in Rheumatoid Arthritis (ERS-RA), a disease-specific cardiovascular disease (CVD) prediction score, in evaluating the 10-year risk, in comparison with other traditional algorithms in patients with rheumatoid arthritis...
Main Authors: | Fausto Salaffi, Marina Carotti, Marco Di Carlo, Marika Tardella, Valentina Lato, Andrea Becciolini, Ennio Giulio Favalli, Andrea Giovagnoni |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2018-08-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/2510 |
Similar Items
-
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events
by: Ennio Giulio Favalli, et al.
Published: (2023-08-01) -
The rheumatoid arthritis impact of disease (RAID) score in telemedicine management of rheumatoid arthritis
by: Taylor, PC
Published: (2024) -
Sarilumab: patient-reported outcomes in rheumatoid arthritis
by: Crotti C, et al.
Published: (2018-08-01) -
Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
by: Raimondo MG, et al.
Published: (2017-05-01) -
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date
by: Crotti C, et al.
Published: (2017-01-01)